The evolving understanding of cystic fibrosis-related diabetes in the highly effective modulator therapy era: a scoping review
Study context
- Population
- People with cystic fibrosis-related diabetes (CFRD) and cystic fibrosis (CF) dysglycaemia in the highly effective modulator therapy era
Main finding
As reported in the abstract
- Review of recent advancements in understanding CF dysglycaemia and CFRD monitoring and treatment, and synthesis of post-market findings on how glycaemic management changes in response to modulator therapy
Original publication
The evolving understanding of cystic fibrosis-related diabetes in the highly effective modulator therapy era: a scoping review. Diabetologia. Published 26 January 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →